| CMSA's 19th Annual Conference & Expo |
 |
|
|
| SY18 |
| Title: |
The Burden and Challenges of Cancer Breakthrough Pain |
|
| Date / Time: |
Friday, June 11, 2010 at 08:00 AM - 09:00 AM |
| Type: |
SYMP-BREAKFAST  |
| Level: |
ADVANCED |
| Sponsor(s): |
|
| Speaker(s): |
Nancy E. Skinner; Connie Sunderhaus |
NOTE: No CEs are available for this Symposium.
Breakthrough pain in cancer can pose a number of challenges to patient management and well-being. The World Health Organization reports that in 85%-97% of all cancer cases, pain can be controlled. Breakthrough cancer pain (BTP) is distinguished from chronic cancer pain by its intensity, intermittency and duration. Risk Evaluation and Mitigation Strategy (REMS) is one of several tools that may be required by the FDA to ensure that the benefits of a drug outweigh its risk. Please join us as we discuss the process, the components and the role of the Case Manager to improve treatment and management options for patients with BTP.
Objectives:
- dentify the challenges and strategies to manage Cancer Breakthrough Pain.
- Explain the rationale for REMS in the opioid class,
- Apply care coordination through every transition of care
|
|
|
This symbol indicates that attendance to this session, event, symposia, breakfast forum, or conference workshop is limited and requires a ticket for admission. Register for these sessions early to ensure admission to the programs of your choice. Sessions have limited seating availability and pre-registration for each of these programs is on a first-come, first-served basis. If seating is still available, unticketed attendees may enter the session 15-minutes after the session starts.
|
|
|
|
|  |
|
|
|